Results 1 to 10 of about 67,362 (119)
Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of second generation TKIs, namely nilotinib and dasatinib, have largely increased the number of CML
Federica Loscocco +14 more
doaj +1 more source
Influence of gut microbiome on multiple myeloma: friend or foe?
Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance.
Marcos de Lima +4 more
doaj +1 more source
A 46‐year‐old man who had undergone hematopoietic stem cell transplant twice because of acute lymphoblastic leukemia with recurrence presented with dyspnea, leading to a diagnosis of pulmonary arterial hypertension which was quickly and effectively ...
Toshikazu D. Tanaka +4 more
doaj +1 more source
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults
The nutritional status of patients submitted to hematopoietic stem cell transplant is considered an independent risk factor, which may influence on quality of life and tolerance to the proposed treatment.
Juliana Bernardo Barban +31 more
doaj +2 more sources
BackgroundPreclinical studies suggest that stem cells may be a valuable therapeutic tool in amyotrophic lateral sclerosis (ALS). As it has been demonstrated that there are molecular changes at the end-plate during the early stages of motorneuron ...
Emilio Geijo-Barrientos +18 more
doaj +1 more source
The advent of bone marrow transplant has opened doors to a different approach and offered a new treatment modality for various hematopoietic stem-cell-related disorders.
Mandeep Singh Rahi +7 more
doaj +1 more source
Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent pandemic have impacted every aspect of oncology care worldwide.
Lindsay Wilde +4 more
doaj +1 more source
Ruxolitinib, an orally bioavailable and selective inhibitor of Janus kinase 1 (JAK1) and JAK2, significantly reduces splenomegaly and disease‐related symptoms in patients with myelofibrosis (MF).
Novella Pugliese +14 more
doaj +1 more source
Methotrexate-Induced Acute Leukemia: Report of Three Cases and Review of the Literature
For many years, methotrexate has been used in the treatment of certain chronic medical disorders e.g. rheumatoid arthritis and psoriasis as well as a number of malignant disorders e.g.
Khalid A. Al-Anazi +3 more
doaj +1 more source
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
Early and late endocrine disorders are among the most common complications in survivors after hematopoietic allogeneic- (allo-) and autologous- (auto-) stem cell transplant (HSCT).
Francesco Orio +9 more
doaj +1 more source

